{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:06:37Z","timestamp":1782846397146,"version":"3.54.5"},"reference-count":17,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n More than 20 million individuals worldwide, especially in the Vidarbha region of India, are affected by sickle cell anemia (SCA), a hereditary condition that results in aberrant hemoglobin S and red blood cell distortion. The condition leads to anemia, organ complications, and recurrent pain crises, making region-specific data necessary for efficient therapy and public health initiatives.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The goal of the study is to examine the clinical characteristics and unusual manifestations of SCA in the Vidarbha region, with an emphasis on dietary practices, clinical presentations, demographic distribution, and lifestyle factors such as alcohol consumption and smoking.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This observational cross-sectional study with random sampling will be conducted at Acharya Vinoba Bhave Rural Hospital in Wardha for 3 months. We will recruit 131 individuals aged 18 to 50 years with dominant hemoglobin S and a positive sickling test. A standardized questionnaire addressing clinical symptoms, nutrition, substance use, inheritance patterns, and demographic information will be used to gather data. SPSS (version 17; IBM Corp) will be used for statistical analysis. Data will be summarized using descriptive statistics. Group differences will be evaluated using inferential tests such as 1-way ANOVA, independent 2-tailed\n t<\/jats:italic>\n tests, and chi-square tests. Associations between symptoms and lifestyle variables will be investigated by correlation analysis. Statistical significance is defined as a 2-tailed\n P<\/jats:italic>\n value <.05.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The anticipated findings may support the need for targeted regional public health initiatives and underscore the importance of comprehensive screening, detailed patient history, and tailored care strategies for individuals with SCA. As of January 2026, this observational study has not received external funding. Participant recruitment and data collection commenced in January 2026 and are currently ongoing. Data analysis will be undertaken following completion of data collection, and the final results are expected to be submitted for publication in April 2026.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The findings will support the need for focused regional public health initiatives and emphasize the need for thorough screening, patient history, and customized care techniques for SCA.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/80483","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:10:07Z","timestamp":1761833407000},"page":"e80483-e80483","source":"Crossref","is-referenced-by-count":0,"title":["Sickle Cell Disease at a Tertiary Care Center in the Vidarbha Region of India: Protocol for a Clinical and Observational Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9209-9916","authenticated-orcid":false,"given":"Tanushree","family":"Budhbaware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-7505","authenticated-orcid":false,"given":"Jaishriram","family":"Rathored","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"2","key":"R1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.1989.03420020120042","volume":"261","author":"Savitt","journal-title":"JAMA"},{"issue":"1","key":"R2","doi-asserted-by":"publisher","DOI":"10.1002\/ggn2.10037","article-title":"Sickle cell disease is a global prototype for integrative research and healthcare","volume":"2","author":"Royal","journal-title":"Adv Genet (Hoboken)"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13045-022-01237-z","article-title":"Advances in the diagnosis and treatment of sickle cell disease","volume":"15","author":"Brandow","journal-title":"J Hematol Oncol"},{"issue":"2","key":"R4","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5020020","article-title":"Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment","volume":"5","author":"Inusa","journal-title":"Int J Neonatal Screen"},{"issue":"38","key":"R5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035237","article-title":"Understanding sickle cell disease: causes, symptoms, and treatment options","volume":"102","author":"Elendu","journal-title":"Medicine (Baltimore)"},{"issue":"6483","key":"R6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1126\/science.aba3827","article-title":"Treating sickle cell anemia","volume":"367","author":"Tisdale","journal-title":"Science"},{"issue":"9","key":"R7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/oxfordjournals.aje.a010288","article-title":"Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review","volume":"151","author":"Ashley-Koch","journal-title":"Am J Epidemiol"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1557\/mrs2010.571","article-title":"Shape and biomechanical characteristics of human red blood cells in health and disease","volume":"35","author":"Diez-Silva","journal-title":"MRS Bull"},{"issue":"3","key":"R9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11340-018-00444-5","article-title":"Faster sickling kinetics and sickle cell shape evolution during repeated deoxygenation and oxygenation cycles","volume":"59","author":"Du","journal-title":"Exp Mech"},{"issue":"6","key":"R10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges, and progress","volume":"109","author":"Goetz","journal-title":"Fertil Steril"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)02047-6","article-title":"MDS-952: Mapping the burden of sickle cell anemia in the tribal region of eastern Maharashtra, India: clinical profile, genotypic patterns, and spousal counseling insights from a 15-year (2009\u20132024) retrospective study","volume":"25","author":"Andankar","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"R12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tcm.2020.02.002","article-title":"Cardiovascular complications of sickle cell disease","volume":"31","author":"Sachdev","journal-title":"Trends Cardiovasc Med"},{"issue":"9","key":"R13","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4067\/S0034-98872021000901322","article-title":"Disease genotype, haplotypes, diagnosis and associated studies in sickle cell anemia","volume":"149","author":"D\u00edaz-Matallana","journal-title":"Rev Med Chil"},{"issue":"8","key":"R14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012082.pub2","article-title":"Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews","volume":"8","author":"Fortin","journal-title":"Cochrane Database Syst Rev"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.944204","article-title":"Editorial: First regulatory approvals for CRISPR-Cas9 therapeutic gene editing for sickle cell disease and transfusion-dependent \u03b2-thalassemia","volume":"30","author":"Parums","journal-title":"Med Sci Monit"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"103060","DOI":"10.1016\/j.transci.2021.103060","article-title":"CRISPR\/Cas9 gene editing for curing sickle cell disease","volume":"60","author":"Park","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"R17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0736-4679(88)90329-0","article-title":"Sickle-cell anemia--a review","volume":"6","author":"Galloway","journal-title":"J Emerg Med"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e80483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:14:00Z","timestamp":1782843240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e80483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":17,"URL":"https:\/\/doi.org\/10.2196\/80483","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"v15i2e80483"}}